British Paper to Illustrate Relationship Between PGx and Society | GenomeWeb

At A Glance

Name: David Melzer

Title: Clinical research associate, Institute of Public Health at University of Cambridge


On July 9, pharmacogenomics will get a brighter spotlight shone on it in the United Kingdom. That day, the Institute of Public Health at the University of Cambridge will publish a paper intended to dissect and explain the role that pharmacogenomics plays in society today.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.